Small Molecule Drug Discovery Market 2026 approaching $117.05 billion by 2030

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Will Be The Estimated Market Valuation Of The Small Molecule Drug Discovery Market By The End Of 2030?

The small molecule drug discovery market has seen rapid expansion in recent years. It is projected to increase from $67.94 billion in 2025 to $75.56 billion in 2026, registering a compound annual growth rate (CAGR) of 11.2%. This historical growth can be attributed to several factors, including enhanced R&D investments by pharmaceutical companies, a rise in the prevalence of chronic diseases, advancements in molecular biology techniques, growing demand for cost-effective therapeutics, and the emergence of contract research organizations (CROs).

The small molecule drug discovery market is projected to experience substantial growth over the coming years, reaching $117.05 billion by 2030 with a compound annual growth rate (CAGR) of 11.6%. This expansion during the forecast period is driven by the integration of AI and machine learning in drug discovery, the expansion of precision medicine initiatives, increasing collaborations between biotech and pharma companies, the adoption of automated high-throughput platforms, and a growing focus on rare and complex diseases. Key trends expected within this period include the widespread adoption of high-throughput screening, advancements in combinatorial chemistry, the integration of nanotechnology in drug design, the development of personalized medicine, and enhancements in target validation and lead optimization.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9834&type=smp

What Primary Drivers Are Shaping The Development Of The Small Molecule Drug Discovery Market?

The increasing prevalence of chronic diseases is anticipated to drive the expansion of the small molecule drug discovery market moving forward. Chronic conditions are defined as those persisting for a year or longer, interfering with daily activities, requiring continuous medical care, or both. Small-molecule medications offer a treatment avenue for such chronic ailments as HIV, cancer, infections, heart disease, and renal disease, often being more cost-effective for patients. This escalating occurrence of chronic diseases is therefore expected to stimulate the small molecule drug discovery market. For example, a 2023 report from the National Institutes of Health (NIH), a US-based biomedical research agency, estimates that 142.66 million people aged 50 and older in the United States will have at least one chronic illness by 2050. Additionally, the population experiencing multimorbidity is projected to reach 14.968 million by 2050. Consequently, the rising incidence of chronic diseases is a significant catalyst for the growth of the small molecule drug discovery market.

Which Segment Classifications Shape The Small Molecule Drug Discovery Market?

The small molecule drug discovery market covered in this report is segmented –

1) By Drug Type: Small Molecule Drugs, Biologic Drugs

2) By Technology: High Throughput Screening, Pharmacogenomics, Combinatorial Chemistry, Nanotechnology, Others

3) By Therapeutic Area: Oncology, Central Nervous System, Cardiovascular, Respiratory, Metabolic Disorders, Gastrointestinal, Others

4) By Process Or Phase: Target ID Or Validation, Hit Generation And Selection, Lead Identification, Lead Optimization

5) By End-User: Pharmaceutical Companies, Contract Research Organizations, Others

Subsegments:

1) By Small Molecule Drugs: Generic Small Molecule Drugs, Novel Small Molecule Drugs

2) By Biologic Drugs: Monoclonal Antibodies, Vaccines, Recombinant Proteins, Cell And Gene Therapies

How Are Trends Impacting The Small Molecule Drug Discovery Market?

Major companies engaged in small molecule drug discovery are establishing collaborations to enhance their market revenues. These alliances frequently stimulate innovation by integrating the specialized knowledge of various organizations. For example, in November 2023, Evommune, a non-profit organization based in the US, and Accutar Biotechnology, a US-based biotechnology firm, announced a strategic partnership concentrated on AI-based drug discovery, with a particular focus on chronic inflammatory diseases. This joint effort aims to utilize Accutar’s proprietary AI platform and Evommune’s expertise to identify novel small molecule drug candidates.

Which Companies Are Expanding Their Footprint In The Small Molecule Drug Discovery Market?

Major companies operating in the small molecule drug discovery market are Pfizer Inc., GlaxoSmithKline plc, AstraZeneca, Boehringer Ingelheim International GmbH, Bristol-Myers Squibb Company, Johnson & Johnson, Gilead Sciences Inc., Merck KGaA, Novartis AG, 4SC AG, Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, Labcorp Drug Development, ICON Public Limited Company, Charles River Laboratories, Aluda Pharmaceuticals, Corcept Therapeutics, Edison Oncology, Escend Pharmaceuticals, Terray Therapeutics, Apollomics, Astex Pharmaceuticals, Pardes Biosciences, Xynomic Pharmaceuticals, Zevra Therapeutics, UNION therapeutics, Allarity Therapeutics, Cyteir Therapeutics, BigHat Biosciences

Read the full small molecule drug discovery market report here:

https://www.thebusinessresearchcompany.com/report/small-molecule-drug-discovery-global-market-report

How Does The Small Molecule Drug Discovery Market Perform Across Major Global Regions?

North America was the largest region in the small molecule drug discovery market in 2025. Europe is expected to be the fastest-growing region in the small molecule drug discovery market report during the forecast period. The regions covered in the small molecule drug discovery market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Small Molecule Drug Discovery Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=9834&type=smp

Browse Through More Reports Similar to the Global Small Molecule Drug Discovery Market 2026, By The Business Research Company

Small Molecule Drug Discovery Market Report 2026

https://www.thebusinessresearchcompany.com/report/small-molecule-drug-discovery-global-market-report

Small Molecule Active Pharmaceutical Ingredient Market Report 2026

https://www.thebusinessresearchcompany.com/report/small-molecule-active-pharmaceutical-ingredient-global-market-report

Rna Targeting Small Molecule Drug Discovery Market Report 2026

https://www.thebusinessresearchcompany.com/report/rna-targeting-small-molecule-drug-discovery-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795